LLY

Eli Lilly and Company Healthcare - Pharmaceuticals Investor Relations →

NO
43.3% ABOVE
↑ Moving away Was 32.1% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $672.26
14-Week RSI 40
Rel. Volume (14w) This week's trading vs. the 14-week average 1.6x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.37

Eli Lilly and Company (LLY) closed at $963.33 as of 2026-05-01, trading 43.3% above its 200-week moving average of $672.26. The stock moved further from the line this week, up from 32.1% last week. The 14-week RSI sits at 40, indicating neutral momentum.

Trading volume is running at 1.6x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.37 ratio) is neutral — neither side is clearly dominating.

Over the past 2765 weeks of data, LLY has crossed below its 200-week moving average 24 times. On average, these episodes lasted 33 weeks. Historically, investors who bought LLY at the start of these episodes saw an average one-year return of +0.2%.

With a market cap of $862.0 billion, LLY is a large-cap stock. The stock trades at 32.5x book value.

The company has been aggressively buying back shares, reducing its share count by 5.8% over the past three years.

Over the past 33.3 years, a hypothetical investment of $100 in LLY would have grown to $16547, compared to $2973 for the S&P 500. That represents an annualized return of 16.6% vs 10.7% for the index — confirming LLY as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

Free cash flow has been growing at a 9% compound annual rate, with 2 consecutive years of positive cash generation.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: LLY vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After LLY Crosses Below the Line?

Across 12 historical episodes, buying LLY when it crossed below its 200-week moving average produced an average return of -4.8% after 12 months (median -9.0%), compared to -0.7% for the S&P 500 over the same periods. 25% of those episodes were profitable after one year. After 24 months, the average return was -4.6% vs +2.3% for the index.

Each line shows $100 invested at the moment LLY crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

LLY has crossed below its 200-week MA 24 times with an average 1-year return of +0.2% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Aug 1973Sep 197358.2%-22.1%+88377.1%
Oct 1973Oct 197310.8%-24.8%+89157.8%
Nov 1973Jun 19742721.2%-8.1%+88935.2%
Jul 1974Feb 19753323.9%+7.1%+91613.6%
Mar 1975May 197578.9%-23.2%+94224.3%
Jul 1975Jul 197815839.3%-25.2%+92256.6%
Sep 1978Sep 197810.1%+28.8%+128091.0%
Oct 1978Dec 1978911.0%+24.0%+136326.8%
Sep 1981Sep 198115.1%+21.4%+116405.4%
Oct 1981Oct 198112.7%+24.4%+113068.1%
Aug 1982Aug 198239.7%+39.0%+112966.6%
Jul 1984Jul 198421.5%+71.3%+88753.4%
Sep 1992Oct 199410732.2%-17.6%+14755.4%
Feb 2000Mar 200034.2%+26.0%+3202.4%
Jan 2002Feb 200242.2%-10.1%+2429.7%
Apr 2002Nov 20038435.8%-17.0%+2393.9%
Nov 2003Dec 200320.3%-18.7%+2533.3%
Jan 2004Feb 200442.6%-14.9%+2580.9%
Mar 2004Apr 200446.2%-21.6%+2527.3%
Jul 2004Oct 200611722.1%-13.9%+2578.3%
Oct 2006Apr 2007249.4%-4.8%+2857.1%
Jul 2007Aug 200722.8%-10.1%+2896.9%
Oct 2007Apr 201118241.3%-37.5%+3006.7%
Aug 2011Aug 201110.5%+31.7%+3791.2%
Average33+0.2%

Frequently Asked Questions

Is LLY below its 200-week moving average?

No. Eli Lilly and Company (LLY) is currently 43.3% above its 200-week moving average of $672.26. It would need to fall to $672.26 to cross below the line.

What is LLY's 200-week moving average price?

Eli Lilly and Company's 200-week moving average is $672.26 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when LLY drops below its 200-week moving average?

LLY has crossed below its 200-week moving average 24 times in our data. On average, buying at that moment produced a one-year return of +0.2%. These dips have historically been decent entry points. These episodes lasted 33 weeks on average.

Is LLY a good value right now?

Here's what our data says about LLY as of 2026-05-01: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 40. Price-to-book is 32.5x. This is not a buy or sell recommendation — always do your own research.

How does LLY compare to the S&P 500?

Over the past 33.3 years, $100 invested in LLY would have grown to $16547, compared to $2973 for the S&P 500. That's 16.6% annualized vs 10.7% for the index. LLY has outperformed the broader market over this period.

Does LLY pay a dividend?

Yes. Eli Lilly and Company currently pays a dividend yield of 65.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-05-01